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Background: Annona muricata (A. muricata) is widely distributed in Asia, Africa and South America. Different parts of this
plant are used to treat several diseases in Cameroon. The aim of this study is to determine the in vitro anti-proliferative
effects and apoptotic events of A. muricata extracts on HL-60 cells as well as to quantify its phenols content.
Methods: The cell viability was measured by using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT)
assay while the changes in morphology of HL-60 cells, membrane mitochondrial potential (MMP) and the cell cycle were
used for assessment apoptosis induction.
Results: The results show that the concentration of phenols, flavonoids and flavonols in the extracts varied depending on
the part of the plant. All the extracts tested inhibited the proliferation of HL-60 cells in a concentration dependent manner
with IC50 varied from 6–49 μg/mL. The growth inhibition of the cells by extracts was associated with the disruption of
MMP, reactive oxygen species (ROS) generation and the G0/G1 cell arrest.
Conclusion: These findings suggest that the extracts from A. muricata have strong antiproliferation potential and can
induce apoptosis through loss of MMP and G0/G1 phase cell arrest.
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Chemopreventive properties have long been attributed
to polyphenolic compounds present in the human diet.
The interest on these natural substances is increasing
because of their higher potential sources of anticancer
compounds. Plants and plant-based medicaments are
used as the basis of many modern pharmaceuticals
industries today for the treatment of our various ailments
[1]. According to world health organization (WHO), more
than 80% of the total world’s population depends on the
traditional medicines to satisfy their primary health care
needs. Several phytochemical molecules from natural
products capable of exerting a physiologic action on the* Correspondence: apieme@yahoo.fr; aksaxena@iiim.ac.in
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unless otherwise stated.human body were studied and characterized. These bio-
active compounds such as alkaloids, flavonoids, tannins
and phenols were considered to be most important. The
phytochemical research that has been done based on the
ethno pharmacological information forms the effective ap-
proach in the discovery of new anti-infective agents from
higher plants [2].
Annona muricata L (A. muricata) commonly known
as graviola, soursop or corossol, belongs to the Annonaceae
family. It is a widespread small tree and has its native in
Central America [3]. It is a typical tropical tree with heart
shaped edible fruits and widely distributed in most of
tropical countries. All parts of A. muricata tree are
used in natural medicine in the tropic including the
twigs, leaf, root, fruit and seeds. Generally, the fruit and
fruit juice are taken to eliminate worms and parasites, cool
fever, increase mother’s milk after child birth, and as an
astringent for diarrhea and dysentery [4]. The crushed
seeds are used against internal and external parasites, headThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and antispasmodic [4]. A decoction of A. muricata leaf is
used to kill bed bug and head lice to reduce fever. For the
latter it can have the same effect taken orally or added to
bathing water [5]. The creamy and delectable flesh of the
fruit consist of 80% water, 1% protein, 18% carbohydrates
and fair amount of vitamins B, B2 and C, potassium and
dietary fiber [6]. The leaf are lanceolate with glossy and
dark green in color had been traditionally used to treat
headaches, hypertension, cough, asthma and used as
antispasmodic, sedative and nervine for heart condition
[7,8]. Previous reports have demonstrated that the leaf,
twigs, root, stem, and fruit seed extracts of A. muricata
have several biological activities such as anti-bacterial [9],
antifungal [10] and anti-malarial [11]. Its leaf extract were
also found to possess antioxidant [12] and molluscicidal
properties [13]. Recently, it has also been reported to
exhibit anti-inflammatory and analgesic effects [14],
cytotoxicity and apoptosis inducing activities on T47D
breast cancer [15], antiviral activity [16] and antidiabetic
activity. Phytochemical investigation of the leaf of A.
muricata showed the presence of alkaloids [17], essen-
tial oils [18] and acetogenins [19]. These acetogenins
demonstrated to be selectively toxic against various
types of the cancerous cells without harming healthy
cells [20]. Acetogenin 1 was reported to exhibit cytotoxic
activities against the human pancreatic tumor cell line
(PACA-2), human prostate adenocarcinoma (PC-3) and
human lung carcinoma (A-549), while Acetogenin 2 was
reported to exhibit cytotoxicity against human hepatoma
carcinoma cell line (Hep G2) [21]. Seven isoquinoline
alkaloids including reticuline, coclaurine, coreximine,
atherosperminine, stepharine, anomurine and anomur-
icine have been isolated from the leaves, root and
stem barks of A. muricata [22]. The essential oil of the
fresh fruit pulp of A. muricata contains 2-hexenoic
acid methyl ester (23.9%), 2-hexenoic acid ethyl ester
(8.6%), 2-octenoic acid methyl ester (5.4%), 2-butenoic
acid methyl ester (2.4%), β-caryophyllene (12.7%), 1,8-
cineole (9.9%), linalool (7.8%), α-terpineol (2.8%), lialyl
propionate (2.2%) and calarence (2.2%) [23]. Therefore,
we attempted to investigate the growth-inhibitory and
apoptotic effects of extracts from leaf, twigs and roots




The plant material including leaf, twigs and roots of
were collected in Yaounde, capital city of Cameroon and
authentified by Mr NANA, a botanist of the National
Herbarium of Cameroon in comparison to the voucher
specimens under the reference number of 3289/HNC.
They were then shade dried and grounded using a blender.The obtained powder was cold macerated with ethanol
95°C with occasional stirring for 3 days. After 3 days, the
suspension was filtered through filtered paper and the
filtrate was evaporated to dryness at low temperature,
using a rotary evaporator. The procedure was repeated 3
times and until total decoloration of the mixture observed.
The obtained extracts were stored and used for further
analysis.
Determination of phenolic composition of the extracts
Total phenol determination
The total phenol was determined by the Folin–Ciocalteu
method, the reaction mixture contains: 200 μL of diluted
spice extract, 800 μL of freshly prepared diluted Folin
Ciocalteu reagent and 2 mL of 7.5% sodium carbonate.
The final mixture will be diluted to 7 mL with deionized
water. Mixture was kept in the dark at ambient conditions
for 2 h to complete the reaction. The absorbance at
765 nm will be measured. Garlic acid was used as
standard and the results were expressed as mg garlic
acid (GAE)/g of dried material.
Determination of total flavonoid content
Total flavonoid content was determined using alumin-
ium chloride (AlCl3) according to a known method
using quercetin as a standard. The spice extract (0.1 mL)
was added to 0.3 mL distilled water followed by 5%
NaNO2 (0.03 mL). After 5 min at 25°C, AlCl3 (0.03 mL,
10%) was added. After further 5 min, the reaction
mixture was treated with 0.2 mL of 1 mM NaOH.
Finally, the reaction mixture was diluted to 1 mL with
water and the absorbance was measured at 510 nm. The
results will be expressed as mg of quercetin (QE)/g of
dried material
Determination of total flavonols
Total flavonols in the plant extracts were estimated
using the method of Kumaran and Karunakaran [24]. To
2.0 mL of sample (standard), 2.0 mL of 2% AlCl3 ethanol
and 3.0 mL (50 g/L) sodium acetate solutions were
added. The absorption at 440 nm was read after 2.5 h
at 20°C. Extract samples were evaluated at a final
concentration of 0.1 mg/mL. Total flavonoid content
was calculated as mg of quercetin (mg/g) using the
following equation y = 5.3911x + 0.0313, R2 = 0.9967 based
on the calibration curve, where x was the absorbance and
y was the concentration of quercetin (mg/g).
Antitumor activity of the extracts
Cell culture
The Human promyelocytic leukemia (HL-60 cells) was
obtained from European Collection of Cells Culture
(ECCC), Sigma–Aldrich, India. They were grown in
RPMI-1640 medium containing 10% Fetal bovine serum
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medium). The cells suspension was kept in the incubator
(Thermo Electron Corporation, USA) at 37°C, 5% CO2;
95% humidity. Cells were used for different assays during
logarithmic growth phase while the untreated control
cultures received only the vehicle (dimethyl sulfoxide
[DMSO] < 0.1%).
Cells viability and treatments
HL-60 cells were seeded in 96 different well plates
containing 15 × 103 μL/well, respectively. The cultured
cells were then treated (triplicate wells per condition)
by adding of 100 μL of serial dilutions of the three
extracts in DMSO to give a final concentration of
100, 30, 10 and 1 μg/mL. In addition, the DMSO
alone was added to another set of cells as the solvent
control (DMSO < 0.1%). The cells were then incubated
for another 48 h prior to the addition of 20 μL of
2.5 mg/mL solution of 3-(4, 5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) into each well.
The incubation was continued for 3 h before the
media was removed. A mixture of DMSO (150 μL)
was added to each well and mixed to ensure dissolving of
the crystal formazan before the absorbance at 570 nm was
measured. Three replications of each experiment were
performed and fifty percent of inhibitory concentration
(IC50) of each extract was calculated.
Hoechst 33258 staining of cells for nuclear morphology
HL-60 cells (2×106 cells/3 mL/well) were treated with
different extracts at different concentrations of extract
for 24 h. They were collected, centrifuged at 400 g
and washed once with PBS. A solution of Hoechst
(Hoechst, 10 μg/mL; citric 10 mM; Na2HPO4 0.45 M;
Tween-20 0.05%) was added in each tube and kept in
the dark at room temperature for 30 min. The mixture
was washed with PBS and the pellet suspended in 100 μL
of PBS/glycerol (1:1). The solution (10 μL) was poured
into the slide and nuclear morphology alterations
observed under fluorescence microscope (Olympus X
70, magnification 20 X) [25].
Reactive oxygen species (ROS) assay
ROS production was monitored by flow cytometry using
2’, 7’- dichlorodihydrofluorescin diacetate (DCFH2-DA).
This dye is a stable non polar compound that readily
diffuses into cells and is hydrolyzed by intracellular
esterase to yield 2’,7’ dichlorodihydrofluorescin (DCFH2),
which is trapped within the cells. Hydrogen peroxide
or low molecular weight peroxides produced by the
cells oxidizes DCFH2 to a highly fluorescent compound
2’,7’-dichlorofluorescein (DCF). Thus, the fluorescence in-
tensity was proportional to the amount of hydrogen per-
oxide produced by the cells. Briefly, HL-60 cells (1 × 106cells/2 mL/well) were treated with extracts of leaf, roots
and twigs of A. muricata at different concentrations
for 24 h. Thirty minutes before the end of the experi-
ment, the cell culture was treated with DCFH2-DA
(50 μM) and kept in the dark. Cells were then collected,
centrifuged (200 g; 4°C; 5 min) and the pellet was
washed with 1 mL of PBS and centrifuged as men-
tioned earlier. The pellet was suspended in 500 μL of
PBS and the fluorescence was assessed by comparing
two fluorescence emission 480 nm/530 nm using a
flow-cytometer (BD-LSR).
Mitochondrial membrane potential (MMP) assay
HL-60 cells (1×106 cells/2 mL/well) were treated with
the three extracts at different concentrations for 24 h.
Thirty minutes before the end of the experiment, the cell
culture was treated with Rhodamine-123 (200nM) and
kept in the dark for 30 mn. Cells were collected, centri-
fuged (400 g; 4°C; 5 min), the pellet was washed with
1 mL of PBS and centrifuged as mentioned earlier. The
depolarization of mitochondrial membrane was exam-
ined by measuring the fluorescence emission shift (red
to green) of the Δψm sensitive cationic Rh-123 dye. The
fluorescence intensity of 10,000 events was analyzed in
FL-1 channel on BD FACS Calibur (Becton Dickinson,
USA) flow cytometer. The decrease in fluorescence inten-
sity because of MMP loss was analyzed in FL-1 channel
and the change of potential membrane (Δψm) was
assessed by comparing fluorescence.
DNA content and cell cycle phase distribution
HL-60 cells (1×106 cells/2 mL/well) were treated with
extracts at 20, 50, 100 μg/mL for 24 h. They were
harvested and washed with 1 mL of PBS, then centrifuged
at 400 g for 5 min at 4°C. The pellet was suspended
in 100 μL of PBS and 900 μL of hypertonic buffer
(PI-25 μg/mL, RNAase- 40 μg/mL, sodium citrate-0.1%
and Triton-100X-0.03%) and incubated at 37°C in dark for
20 min. Finally, cells were analyzed immediately on flow
cytometer FACS Calibur (Becton Dickinson, USA). The
data were collected in list mode on 10,000 events and
illustrated in a histogram, where the number of cells
(counts) is plotted against the relative fluorescence inten-
sity of PI (FL-2; λem: 585 nm; red fluorescence). The
resulting DNA distributions were analyzed by Modfit
(Verity Software House Inc., Topsham, ME) for the
proportions of cells in G0/G1, S phase, and G2/M
phases of the cell cycle [26].
Statistical analysis
The viability experiments were done in triplicates and
each data point represents the average of at least 3
independent experiments. The distributions of the data
are abnormal. The data was expressed as mean ± SD. In
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analyzed using SPSS (Version 11.5; SPSS Inc.,) and M.S.
Office, Excel software. One way analysis of variance
technique was applied to observe the significance be-
tween the groups. The post hoc test Duncan’s multiple
range test was performed to know the significant differ-
ence among the groups. Entire statistical analysis was
carried out at p < 0.05.
Results
Phenolic contents of A. muricata
The results of this study showed that the level of poly-
phenols, flavonoids and flavonols varied depending on
the part of the plant (Table 1). The concentration of
these three groups of molecules is higher in the leaves
compare other parts of plant extract. The lowest concen-
tration of flavonoids and flavonols was found on the
stem barks of A. muricata while its roots show the lower
phenols content.
In vitro anticancer activity
Effects of A. muricata extracts on the proliferation of HL-60
In this study we used a microculture assay based on
metabolic reduction of MTT to evaluate the cytotoxic
effect extracts of A. muricata on HL-60 cells. This tech-
nique permitted us to evaluate dose-dependent effect, by
linear regression analysis showing acceptable R2 values
and correlation coefficients. As shown in the Figure 1,
the addition of extracts at different concentration to the
cultured cells inhibited dramatically and significantly the
proliferation of the cells in a dose-dependent manner.
The values of IC50 of the extract after 48 h was between
6–12 μg/mL which is lower than 20 μg/mL (Table 1).
Morphological changes of apoptotic treated HL-60 cells
with A. muricata extracts
To investigate of A. muricata extracts on the nuclear
modification on HL-60 cells, the Hoechst 33258 staining
test was performed at different concentrations (20, 50
and 100 μg/mL) after 24 h of treatment. Hoechst 33258
reagent is a membrane-permeable blue fluorescent dye
which stained cell nucleus. As observed in Figure 2, the
control or untreated cells present the characteristics of
healthy cells. They appeared to be intact oval shape and
the uniform nuclei were stained with a less bright blue
fluorescence. Cells treated with tested extracts exhibitedTable 1 Phenolic composition and fifty percent inhibition of e




T 49 ± 3.2b 19.88 ± 1.52b
R 9 ± 0.8a 13.01 ± 0.58c
L 14 ± 2.4b 23.07 ± 1.56a
Values are represented as mean ± SD, n = 3; L: Leaf; R: Roots; T: twigs, Values affectea bright blue color when the concentration of extract
increases. These results demonstrated typical features
of apoptosis such as cell shrinkage, chromatin conden-
sation, and fragmentation to multiple aggregate of
apoptotic bodies and cell decrement (Figure 2). The
apoptotic nuclei clearly showed highly condensed or
fragmented chromatin. At 100 μg/mL, most of the
cells undergo apoptosis and the number of apoptotic
bodies increases.A. muricata extracts induce apoptosis by generation of ROS
To investigate whether extracts of A. muricata inhibit
the HL-60 cells by through the generation of ROS, we
monitored the redox status of the HL-60 treated cells
using the oxidation sensitive fluorescent dye DCFDA. As
shown in Figure 3A, B and C, the ROS levels generated
after 24 h treatment of HL-60 cells varied with the con-
centration of extract and the part of plant used in the
study. However, the higher ROS levels were found at the
concentration of 20 μg/mL (9.99% for twigs), 50 μg/mL
(4.08% for Leaf ) and 100 μg/mL (3.07% for the twigs)
(Figure 3D). At the higher concentration (100 μg/mL),
the ROS produced by cells with the extract of the roots
and leaves were lower than that of untreated control
cells (Figure 3D).A. muricata extracts disrupt mitochondrial membrane
potential in HL-60 cells
After treatment of cells with extracts at different concentra-
tion, we observed an increase of fluorescence intensity indi-
cating the mitochondrial membrane depolarization as
Figure 4A, B & C. The depolarization of mitochondrial
membrane varied with concentration and the extracts. A
dose-dependent increase of fluorescence observed is ran-
ging from 17.34% to 98.91% (Figure 4B). Among the
extract tested, the twigs extract demonstrated a higher
depolarization of mitochondrial membrane (21.75%) at
20 μg/mL while those of leaf and roots showed a max-
imum depolarization at 100 μg/mL (98.29 and 98.91%
respectively). All the extracts at 50 μg/mL exhibited
more than 50% of depolarization of mitochondrial
membrane (Figure 4D). These results show that extracts
induced apoptosis on HL-60 cells after 24 h through the







6.03 ± 0.92b 2.40 ± 0.90b
6.82 ± 1.35b 3.63 ± 2.81b
9.96 ± 1.53a 6.57 ± 1.42a
d with different letters are significantly different (p < 0.05).
Figure 1 Viability of HL-60 cells after 48 h treatment with extracts of A. muricata; (n = 3); (A) HL-60 cells; L (Leaf); R (Roots); T (twigs).
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HL-60 cells
The changes in the cell cycle distribution were shown in
Figure 5A and the apoptotic cells were counted based
on G0 DNA contents. The results show no changes in
the cell cycle distribution of the control group, however,
the accumulation of cells was found in apoptotic (G0)
with significant modification of G2/M and S phases
when the concentration of all the tested extracts in-
crease (Figure 5A, B & C). The cell population of G0A
B
C
Figure 2 Effect of extracts A. muricata on nuclear morphological chan
Hoechst 33258 incubated for 30 min, and observed under fluorescence mi
morphological changes of cell apoptosis such as condensation of chromat
gradually increased in a dose-dependent manner; (A): Leaf; (B): Roots; (C):phase significantly increased from 2.51 – 96% (leaf ),
2.83 – 95% (roots) and 5.01 – 98% (twigs) and in the
meantime the proportion G0/G1drastically increased
(Figure 5D). The results demonstrated that all the
tested extracts induced apoptosis on HL-60 cells
through G0/G1 phase cell cycle arrest.
Discussion
Natural polyphenols are secondary metabolites produced
by plants for their defense against different types ofges of HL-60 cells. After 24 h of treatment cells staining with
croscope. Olympus,Tokyo, Japan; magnification 200×. Marked





Figure 3 Effects of extracts A. muricata on ROS production on HL-60 cells; cells were treated with extract for 24 h followed by staining
with DCHFH2-DA (50 μM), incubated for 30 min and the fluorescence in the cells was immediately analyzed using flow cytometry.
Data are presented the fluorescence intensity; (A): Leaf; (B): Roots; (C): twigs: (D); Variation of ROS production of extracts of A. muricata; values are
expressed as means ± standard error (n = 3). Values affected with different letters are significantly different (p < 0.05) from the control. L: Leaf;
R: Roots; T: twigs, Ctl: control; app: apoptic phase.
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low soil fertility, changes of environmental temperature,
severe drought, and grazing pressure [27]. The interest
on plant phenols is increasing in the recent decade
because of their health promoting potential. It is widely
known that diets containing an abundance of phenols
have protective effects against a variety of diseases, par-
ticularly cardiovascular disease and cancer. Phenols from
herbal extract are raising great interest as powerful and
safe anticancer strategy for their broad range targeting
capability and low side effects. Depending on the chem-
ical structure, several beneficial effects of polyphenols
and their implications in the human health have been
identified including in cancer [28], neuroprotection
[6,29], cardiovascular system dysfunction and damage,
the metabolic syndrome, diabetes, aging, and different
inflammation-related pathologies [27,30,31]. Chemother-
apy drugs from polyphenols could improve the survival
of cancer patients, with low side effects. Thus, it is ur-
gent to develop novel drugs which are more effective[32]. Novel strategies for determination of natural prod-
ucts with biological activity require the implementation
of large-scale screening programs.
The antiproliferative activities of A. muricata have
been carried out on several cancer cells with significant
positive results [15,21]. Plant extracts with IC50 values ≤
30 μg/mL are considered pharmaceutically active [33].
Our MTT results (Table 1) indicated that extracts of A.
muricata inhibited significantly the HL-60 cells in vitro
and can be considered as active according to the sug-
gestions from the National Cancer Institute (NCI)
which stated that the IC50 lower or equal to 20 μg/mL
can be used as a benchmark for suitable screening
cancer drugs from plants and herbs [34]. A dose-
dependent inhibitory effect of extracts was also ob-
served in HL-60 treated cells (Figure 1A). Among
these extracts the roots exhibited the higher cytotoxic
effects than other extracts (Table 1). Our results dem-
onstrated that A. muricata extracts have significant
cytotoxic potential on HL-60 cells.
A B
C
Figure 4 Effects of extracts of A. muricata on the integrity of mitochondrial membrane, HL-60 cells were treated different concentrations of
extracts, incubated 1 h with 200 nM of Rh-123 and then analyzed by flow cytometry. Data are presented the fluorescence intensity: (A): Leaf;
(B): Roots; (C): twigs: (D); Variation of the integrity of mitochondrial membrane by extracts of A. muricata; values are expressed as means ± standard
error (n = 3). Values affected with different letters are significantly different (p < 0.05) from the control. L: Leaf; R: Roots; T: twigs; Ctl: control.
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which is an active physiological process to eliminate
selectively unnecessary cells [35]. Induction of cell
apoptosis in tumor tissue is the best stage for cancer
therapy [35]. Apoptosis is a common mode of action of
chemotherapeutic agents, including the natural product-
derived drugs. Furthermore, induction of apoptosis is rec-
ognized as an efficient strategy for cancer chemotherapy
and a useful indicator for cancer treatment and preven-
tion. Hence several researchers nowadays have performed
apoptotic screening of natural products from herbal
extracts in Cameroon [36,37]. Apoptosis involves specific
morphological and biochemical changes such as chroma-
tin condensation, membrane blebbing, cell shrinkage,
DNA fragmentation, etc. Induction of apoptosis is the key
to success of plant products as anticancer agents [38,39].
After 24 h of treatment with A. muricata extracts, the
characteristics of apoptotic cells, including the increase of
bright blue color of Hoechst 33258 staining was observed
(Figure 2A, B & C) as well as evident DNA fragmentations
at 100 μg/mL, which are the important hallmarks ofapoptosis [40]. The results indicated that all the extracts
from A. muricata induce apoptosis of HL-60 cells.
Mitochondrion is an integral part of apoptotic machin-
ery and events such as loss of mitochondrial membrane
potential is classical evidence for apoptosis [35]. Usually,
the decrease in MMP occurs during the early stage of
apoptosis before the cell morphology changes. The sharp
decrease in the membrane potential indicates the irre-
versible occurrence of early apoptosis due to an increase
in the permeability of the mitochondrial membrane
follow by the release of apoptotic factors, including
cytochrome c [41]. Based on the current research, we
propose that the following mechanism is responsible for
extracts-induced HL-60 cell apoptosis. Briefly, extracts
of A. muricata acts through the disruption of membrane
mitochondrial to arrest cells in the G0/G1 phase and in-
hibit cell proliferation. Cell cycle checkpoints are control
mechanisms that ensure the proper progression of cell
cycle events [42]. In vitro apoptosis assay study pre-
sented here (Figure 5A, B, C), showed that extracts from




Figure 5 Cell cycle analysis of extracts of A. muricata on HL-60 cells. After 24 h, treated cells were incubated with RNAse (40 μg/mL),
stained with propidium iodide (25 μg/mL), and analyzed by BD-FACS Caliber flow-cytometer; (A): Leaf; (B): Roots; (C): twigs; Cells distribution after
treatment with extracts of A. muricata; values are expressed as means ± standard error (n = 3). Values affected with different letters are significantly
different (p < 0.05) from the control. L: Leaf; R: Roots; T: twigs; Ctl: control; app: apoptic phase.
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this experiment, the extracts of A. muricata induced
G0/G1 cell cycle arrest in HL-60 cells at different
concentration after 24 h of treatment (Figure 5A, B, C).
Therefore, we can suggest that the anticancer effects of
A. muricata extract is associated with G0/G1 cell cycle
arrest and cell differentiation. The cell cycle analysis re-
vealed that all the extracts of A. muricata can markedly
induce a G0/G1 phase arrest in HL-60 cells, but they
have low effects on the G2/M phase. Although the
induction mechanism of cell differentiation by A.
muricata extract is not clear, a block of cell cycle
progression at the G0/G1 phase may be closely related
to the differentiation.
Most chemopreventive agents known today from plant
extracts are subdivided into two categories: (i) blocking
agents which inhibit the initiation step by preventingcarcinogen activation and (ii) suppressing agents, which
inhibit malignant cell proliferation during promotion
and progression steps of carcinogenesis [43]. Natural
products, including medicinal plants, herbs and spices
provide rich resources for anticancer drug discovery
[44]. Phytochemical analysis of the extracts of A.
muricata was performed in order to identify the
chemical nature of the active principles. Quantitative
analysis of the extracts revealed the presence of
phenolics, flavonoids and trace amounts of flavonols
(Table 1). Previous studies, demonstrated the presence
of a number of phytochemicals, including phenols as
flavonoids, tannins, anthraquinones and steroids in
the leaf extracts of A. muricata [45]. Cinnamic acid
derivative, Coumaric acid hexose, 5-Caffeoylquinic acid,
Dihydrokaempferol-hexoside, p-Coumaric acid, Caffeic acid
derivative and Dicaffeoylquinic acid represented phenolics
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ical investigations of the leaves and seeds of A. muricata
have resulted in the isolation and identification of a great
number of acetogenins with interesting biological or
pharmacological activities, such as antitumoral, cytotoxicity
and apoptosis on HCT-116 and HT-29 cancer cells, [16,47].
Hence, previous studies revealed that several acetogenins
act as a DNA topoisomerase I poison, arrested cancer cells
at the G1 phase and induced apoptotic cell death in a Bax-
and caspase-3- related pathways, and inhibited NADH-
ubiquinone oxidoreductase (complex I) in mitochondria
[21]. It can be suggested that the synergistic effects of
phytochemicals present in this plant extracts including
acetogenins may be the underlying principle behind
the chemotherapy potential agents of A. muricata.
These groups of molecules found in a large quantity in
A. muricata extracts may act in synergy and might be
responsible for their antiproliferation activity through
the significant decrease in the mitochondrial membrane
potential induction of apoptosis.
Conclusions
In conclusion, A. muricata exhibit antiproliferative ef-
fects of HL-60 cells by inducing loss of cell viability,
morphology changes, loss of membrane mitochondrial
potential and G0/G1 phase cell arrest. Our data confirm
the potential of A. muricata as an agent of chemothera-
peutic and cytostatic activity in HL-60 cells. These data
suggest that these extracts have potential for cancer
chemotherapy. However, the complete mechanisms
underlying the therapeutic effects of the extracts need to
be investigated as well as the identification of the active
molecules present in the different parts of the plant.
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